MARK FINLEY: Open Payments
NPI 1992077333 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,488 in 139 payments from 19 companies in 2025. Trend: 2023 $2,149 · 2024 $2,193 · 2025 $2,488
Food & beverage: $2,202Education: $285
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $320 |
| LEO Pharma Inc. | 19 | $288 |
| Lilly USA, LLC | 19 | $287 |
| GENZYME CORPORATION | 11 | $263 |
| Novartis Pharmaceuticals Corporation | 23 | $258 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $237 |
| ABBVIE INC. | 15 | $180 |
| Galderma Laboratories, L.P. | 10 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Janssen Biotech, Inc. | 4 | $91 |
Products named: DUPIXENT, COSENTYX, ADBRY, TALTZ, NEMLUVIO, EBGLYSS, ILUMYA, ANZUPGO.
Industry payments across GA — which companies pay providers there.
